Literature DB >> 15079817

CTb targeted non-viral cDNA delivery enhances transgene expression in neurons.

L B Barrett1, M Berry, W-B Ying, M N Hodgkin, L W Seymour, A-M Gonzalez, M L Read, A Baird, A Logan.   

Abstract

BACKGROUND: Efficient neuronal gene therapy is a goal for the long-term repair and regeneration of the injured central nervous system (CNS). We investigated whether targeting cDNA to neurons with cholera toxin b chain conjugated non-viral polyplexes led to increased efficiency of non-viral gene transfer in the CNS. Here, we illustrate the potential for this strategy by demonstrating enhanced transfection of a differentiated neuronal cell type, PC12.
METHODS: In vitro transfection efficiency of a cholera toxin b chain-poly(D-lysine) molecular conjugate (CTb-K(100)) was compared by fluorescence-activated cell sorting (FACS) analysis of green fluorescent protein (GFP) expression and luminometric measurement of beta-galactosidase (beta-gal) expression, to untargeted poly(D-lysine) (K(100)) in undifferentiated and NGF-differentiated PC12 cells.
RESULTS: Transfection of undifferentiated PC12 cells with CTb-K(100) polyplexes resulted in a 36-fold increase in levels of pCMV-DNA(LacZ) expression and a 20-fold increase in the frequency of transduction with pCMV-DNA(GFP), compared with untargeted K(100) polyplexes. Treatment of PC12 cells with 50 ng/ml/day of NGF for 14 days led to differentiation to a neuronal phenotype. Transfection of NGF-differentiated cells with CTb-K(100) polyplexes resulted in a 133-fold increase in levels of pCMV-DNA(LacZ) expression and a 11-fold increase in the percentage of cells transduced with pCMV-DNA(GFP), compared with untargeted K(100) polyplexes. Transfection was dependent on CTb, with CTb-K(100)-mediated transfections competitively inhibited with free CTb in both PC12 phenotypes.
CONCLUSIONS: Non-viral systems for gene transfer in damaged CNS show superior toxicological profiles to most viruses but are limited by inefficient and non-selective gene expression in target tissue. Cholera toxin is known to interact preferentially with neuronal cells of the central and peripheral nervous systems, mediating binding through the b subunit, CTb, and the pentasaccharide moiety of the gangliosaccharide, GM1, which is present at high levels on the neuronal cell surface. Here, we show that a molecular conjugate of the CTb subunit, covalently linked to poly(D-lysine), is able to successfully target and significantly enhance transfection of a neuronal cell type, NGF-differentiated rat PC12 pheochromocytoma cells. This observation encourages the further development of non-viral strategies for the delivery of therapeutic genes to neurons. Copyright 2004 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15079817     DOI: 10.1002/jgm.524

Source DB:  PubMed          Journal:  J Gene Med        ISSN: 1099-498X            Impact factor:   4.565


  4 in total

1.  Neuron-specific delivery of nucleic acids mediated by Tet1-modified poly(ethylenimine).

Authors:  In-Kyu Park; Jurate Lasiene; Shinn-Huey Chou; Philip J Horner; Suzie H Pun
Journal:  J Gene Med       Date:  2007-08       Impact factor: 4.565

Review 2.  Breaking Barriers: Bioinspired Strategies for Targeted Neuronal Delivery to the Central Nervous System.

Authors:  Ana P Spencer; Marília Torrado; Beatriz Custódio; Sara C Silva-Reis; Sofia D Santos; Victoria Leiro; Ana P Pêgo
Journal:  Pharmaceutics       Date:  2020-02-23       Impact factor: 6.321

Review 3.  "Alternative" endocytic mechanisms exploited by pathogens: new avenues for therapeutic delivery?

Authors:  L K Medina-Kauwe
Journal:  Adv Drug Deliv Rev       Date:  2007-07-05       Impact factor: 15.470

4.  Directed Assembly of Homopentameric Cholera Toxin B-Subunit Proteins into Higher-Order Structures Using Coiled-Coil Appendages.

Authors:  James F Ross; Gemma C Wildsmith; Michael Johnson; Daniel L Hurdiss; Kristian Hollingsworth; Rebecca F Thompson; Majid Mosayebi; Chi H Trinh; Emanuele Paci; Arwen R Pearson; Michael E Webb; W Bruce Turnbull
Journal:  J Am Chem Soc       Date:  2019-03-21       Impact factor: 15.419

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.